MedTrace Logo

Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration

NCT01361256 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2020-07-10

No results posted yet for this study

Summary

This is a pilot study to evaluate the safety of the Model WA-NG telescope prosthesis in patients with bilateral moderate to profound central vision impairment due to end-stage age-related macular degeneration.

Conditions

  • Age Related Macular Degeneration

Interventions

DEVICE

Telescope prosthesis

Monocular implantation of the telescope prosthesis after cataract extraction

DEVICE

WA-NG Telescope Prothesis

The WA-NG telescope prosthesis (Figure 1) is the next generation telescopic implantable device which, when combined with the optics of the cornea, constitutes a telephoto system for improvement of visual acuity in patients with severe to profound vision impairment due to bilateral, end-stage age-related macular degeneration. The device is implanted in one of the patient's eyes. In this way, the implanted eye provides central vision and the non-implanted eye can continue to provide peripheral vision.

Sponsors & Collaborators

  • VisionCare, Inc.

    lead INDUSTRY

Principal Investigators

  • Mordecai Rosner, MD · Sheba Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2015-04-30
Completion
2016-05-31

Countries

  • Israel

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361256 on ClinicalTrials.gov